Vimentin's association with aggressive, mesenchymal-like transformation supports its utility in identifying high-grade gliomas such as DMGs, while synaptophysin expression points toward neuronal differentiation, favoring a diagnosis of oligodendroglioma. The gene discussed is VIM; the disease is central nervous system cancer.